NVIDIA Commercial and Professional Services Global

Deloitte Consulting LLP

Deloitte needed to integrate large multimodal biomedical datasets, train custom protein and chemistry language models, and assemble drug-discovery pipelines far faster than manual infrastructure work allowed, because traditional drug development is slow, costly, and prone to failure.

12 million nodes and 97 million connection edge links in the Atlas AI graph
5 terabytes of raw multimodal data searchable within seconds
50% improvement in developer productivity
7–10 months saved by eliminating manual setup for multi-node training

Reported impact

Business outcome

Deloitte boosted developer productivity by 50 percent, saved 7–10 months of multi-node infrastructure work, reduced training runs from four weeks to eight hours, and shrank pipeline assembly from 4–6 weeks to a few clicks while enabling richer molecular ranking and generation workflows for drug discovery.

  • Cost Reduction
  • Productivity Improvement
  • Speed to Market

Solution

Deloitte built Quartz Atlas AI on NVIDIA DGX Cloud running on Oracle Cloud Infrastructure to turn multimodal drug-discovery research into a scalable, reusable pipeline. Atlas AI combines LLM-powered knowledge graphs, NVIDIA BioNeMo microservices, and Deloitte’s proprietary generative models to ingest sources such as PubMed, UniProt, antibody datasets, and small-molecule datasets into a 12-million-node, 97-million-edge graph totaling 5 TB of raw data. The platform uses AlphaFold2, OpenFold, and ESMFold for structure prediction, MegaMolBART and MolMIM for molecule generation, and DGX Cloud-based multi-node training to fine-tune protein and chemistry models such as a 15B-parameter ESM2 variant. NIM microservices then serve those models at scale so researchers can rank compounds, refine proteins, run inference loops, and generate comprehensive reports without manually wiring infrastructure or debugging bespoke pipelines for every experiment.

Data flow

Scientific literature, protein, antibody, and small-molecule datasets are loaded into Quartz Atlas AI, DGX Cloud trains BioNeMo and Deloitte models on the multimodal graph, NIM serves structure and molecule models such as AlphaFold2 and MolMIM, and researchers receive ranked compounds, predicted properties, and generated reports for downstream wet-lab decisions.

Solution architecture

10 components · 2 layers
  1. Compute
    • NVIDIA DGX Cloud Provides the scalable multi-node training and experimentation environment for Deloitte’s models.
    • Oracle Cloud Infrastructure Hosts the DGX Cloud deployment and low-latency fabric used for the training cluster.
    • NVIDIA BioNeMo Supplies structure-prediction, molecule-generation, and model-training building blocks for the pipeline.
  2. Serving
    • Quartz Atlas AI Acts as Deloitte’s generative AI drug-discovery accelerator and multimodal knowledge-graph environment.
    • NVIDIA NIM Serves BioNeMo and Deloitte models for scalable inference and pipeline orchestration.
    • AlphaFold2 Performs protein structure prediction inside the Atlas AI workflow.
    • OpenFold Provides additional protein-folding inference inside the structure-prediction stack.
    • ESMFold Adds protein-structure modeling capacity within Deloitte’s multimodal pipeline.
    • MegaMolBART Supports molecule generation and mapping inside the solution space.
    • MolMIM Generates and optimizes novel compounds against user-defined molecular scoring targets.

Architecture clues

  • Atlas AI loads over a dozen multimodal biomedical datasets into a large generative knowledge graph.
  • Deloitte fine-tuned a 15-billion-parameter ESM2 model on DGX Cloud for protein-property prediction.
  • The pipeline mixes structure prediction, molecule generation, and inference loops so researchers can iteratively refine candidates.

Evidence from the source

By enabling us to easily run more concurrent experiments compared to our previous solution ... DGX Cloud has boosted developer productivity by 50 percent.
Deloitte is using NVIDIA BioNeMo models, available as NVIDIA NIM microservices, including AlphaFold2, OpenFold, and ESMFold for protein structure prediction, alongside MegaMolBART and MolMIM for molecule generation.
Our training runs have been reduced from four weeks to just eight hours.
We created a robust generative AI-powered knowledge graph with Atlas AI, loading over a dozen datasets, which amounts to 12 million nodes and 97 million connection edge links, totalling 5 terabytes in raw volume, searchable within seconds.
With DGX Cloud, multi-node training is now as easy as clicking a button, saving us seven to 10 months of infrastructure and tooling work.
Transparency Evidence & methodology 100/100 reference value · 89% confidence · 1 source

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value100/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth25/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact25/25
    5 metrics describe measurable impact.
  • Deployment scale10/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence89%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability21/25
    10 of 12 key fields link to a named source.
  • Direct evidence20/20
    5 direct source quotes retained.
  • Date provenance10/10
    The publication date comes from the source page or publisher.
  • Source transparency8/10
    1 source reference document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. NVIDIA

    Deloitte Consulting LLP customer story

    First-party
    https://www.nvidia.com/en-us/case-studies/generative-ai-in-drug-discovery/
    Source type
    Vendor-published customer story
    Published
    Aug 13, 2025
    Supports
    • Customer
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • technical area
    • use case category
    • Business outcome
    • outcome category
    • Metrics
    • Architecture
    • evidence quotes
    • Publication date

Date evidence

  • Published on source page Aug 13, 2025 · NVIDIA · First-party
    Open date source
Not separately sourced Industry, Region, Company size. Treat these normalized attributes as lower-confidence until a dedicated source is added.